IOVANCE BIOTHERAPEUTICS INC

$IOVA
Smart money positioned

9 of the Top-200 alpha managers hold $IOVA as of the latest 13F snapshot.

13F holders
287
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

9 holders · Q1 2026

$IOVA is held by 9 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.18%, with an average of 0.06% of portfolio. Largest holder: Diadema Partners LP at 0.18%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 287 · Source: 13F-HR
01
Sectoral Asset Management Inc.
7.43% of portfolio
28,967,103 sh
02
State Street
20,161,445 sh
03
Axa S.a.
17,448,108 sh
04
Leuthold Group, LLC
0.04% of portfolio
13,687,433 sh
05
Invenomic Capital Management LP
1.11% of portfolio
10,541,608 sh
06
Evergreen Capital Management LLC
0.01% of portfolio
9,414,292 sh
07
Brooks, Moore & Associates, Inc.
1.37% of portfolio
8,495,551 sh
08
Commerce Bank
0.02% of portfolio
8,016,353 sh
09
Madison Asset Management, LLC
3.41% of portfolio
6,349,563 sh
10
Brightline Capital Management, LLC
5,127,300 sh
See all 287 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $IOVA in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $IOVA in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 12:49 UTC.